Cargando…
Hsp90 is a potential risk factor for ovarian cancer prognosis: an evidence of a Chinese clinical center
BACKGROUND: The potential treatment effects of heat shock protein 90 (Hsp90) inhibitors in ovarian cancer (OC) are controversial. This research aims to investigate the relationship between the level of Hsp90 in peripheral blood and the prognosis of OC patients, as well as the clinicopathological ind...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230804/ https://www.ncbi.nlm.nih.gov/pubmed/37259027 http://dx.doi.org/10.1186/s12885-023-10929-9 |